Sun Pharma Advanced Research Company Limited announced unaudited standalone earnings results for the third quarter and nine months ended December 31, 2017. For the quarter, the company reported revenue from operations of INR 194.2 million against INR 230.5 million a year ago. Total income was INR 215.5 million against INR 259.5 million a year ago. Loss before tax was INR 580.7 million against INR 660.2 million a year ago. Net loss was INR 580.7 million against INR 660.2 million a year ago. Diluted loss per share was INR 2.34 against INR 2.67 a year ago. For the nine months, the company reported revenue from operations of INR 581.7 million against INR 1,394.2 million a year ago. Total income was INR 625.3 million against INR 1,493.5 million a year ago. Loss before tax was INR 1,994.8 million against INR 871.5 million a year ago. Net loss was INR 1,994.8 million against INR 871.5 million a year ago. Diluted loss per share was INR 8.07 against INR 3.53 a year ago.